Ding et al., 2024 - Google Patents
Follicular CD8+ T cells promote immunoglobulin production and demyelination in multiple sclerosis and a murine modelDing et al., 2024
- Document ID
- 3975797676059826900
- Author
- Ding J
- Zhang J
- Zhao S
- Jiang D
- Lu J
- Yang S
- Wang J
- Sun Y
- Huang Y
- Hu C
- Zhang X
- Zhang J
- Liu T
- Han C
- Qiao X
- Guo J
- Zhao C
- Yang K
- Publication year
- Publication venue
- Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease
External Links
Snippet
Emerging evidence underscores the importance of CD8+ T cells in the pathogenesis of multiple sclerosis (MS), but the precise mechanisms remain ambiguous. This study intends to elucidate the involvement of a novel subset of follicular CD8+ T cells (CD8+ CXCR5+ T) in …
- 201000006417 multiple sclerosis 0 title abstract description 72
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Hybridisation probes
- C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
- C12N5/0602—Vertebrate cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Psarras et al. | Functionally impaired plasmacytoid dendritic cells and non-haematopoietic sources of type I interferon characterize human autoimmunity | |
Liang et al. | A gene network regulated by the transcription factor VGLL3 as a promoter of sex-biased autoimmune diseases | |
Wambre et al. | A phenotypically and functionally distinct human TH2 cell subpopulation is associated with allergic disorders | |
Tew et al. | Association between response to etrolizumab and expression of integrin αE and granzyme A in colon biopsies of patients with ulcerative colitis | |
Xia et al. | IL4 (interleukin 4) induces autophagy in B cells leading to exacerbated asthma | |
Gandoura et al. | Gene-and exon-expression profiling reveals an extensive LPS-induced response in immune cells in patients with cirrhosis | |
Ayano et al. | Increased CD226 expression on CD8+ T cells is associated with upregulated cytokine production and endothelial cell injury in patients with systemic sclerosis | |
Fiore et al. | Induction of immunosuppressive functions and NF-κB by FLIP in monocytes | |
Rao et al. | Cytokines regulate the antigen-presenting characteristics of human circulating and tissue-resident intestinal ILCs | |
Fu et al. | An IL-9–pulmonary macrophage axis defines the allergic lung inflammatory environment | |
Wing et al. | Interleukin‐17‐and interleukin‐22‐secreting myelin‐specific CD 4+ T cells resistant to corticoids are related with active brain lesions in multiple sclerosis patients | |
Miller et al. | Hypomethylation of STAT1 and HLA-DRB1 is associated with type-I interferon-dependent HLA-DRB1 expression in lupus CD8+ T cells | |
Piatek et al. | C5a-preactivated neutrophils are critical for autoimmune-induced astrocyte dysregulation in neuromyelitis optica spectrum disorder | |
Verma et al. | Unbiased immune profiling reveals a natural killer cell-peripheral nerve axis in fibromyalgia | |
Castiglioni et al. | Combined PD-L1/TGFβ blockade allows expansion and differentiation of stem cell-like CD8 T cells in immune excluded tumors | |
He et al. | Sumoylation of RORγt regulates TH17 differentiation and thymocyte development | |
WO2018025923A1 (en) | Anti-htlv-1 drug and therapeutic agent for htlv-1-associated myelopathy/tropical spastic paraparesis (ham/tsp) | |
Cárdenas et al. | Neurocysticercosis: the effectiveness of the cysticidal treatment could be influenced by the host immunity | |
Linnerbauer et al. | PD-L1 positive astrocytes attenuate inflammatory functions of PD-1 positive microglia in models of autoimmune neuroinflammation | |
Lewis et al. | Differential dynamics of peripheral immune responses to acute SARS-CoV-2 infection in older adults | |
Chen et al. | Differential metabolic requirement governed by transcription factor c-Maf dictates innate γδT17 effector functionality in mice and humans | |
Oyesola et al. | Exposure to lung-migrating helminth protects against murine SARS-CoV-2 infection through macrophage-dependent T cell activation | |
Funk et al. | Aged intestinal stem cells propagate cell-intrinsic sources of inflammaging in mice | |
Wang et al. | Sex-specific circulating unconventional neutrophils determine immunological outcome of auto-inflammatory Behçet’s uveitis | |
Yap et al. | B cell subsets and cellular signatures and disease relapse in lupus nephritis |